SYNBIOTIC THERAPY (BIFIDOBACTERIUM LONGUM/SYNERGY 1) INITIATES RESOLUTION OF INFLAMMATION IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS
While the use of probiotics to aid in the treatment of inflammatory bowel disease is not new, sometimes it’s nice just to reaffirm the efficacy and safety of this approach with a wide range of GI disorders.
Once again, we see that the long term damaging effects of antibiotic use extend well beyond the fear of antibiotic resistance.